Maa: Yhdysvallat
Kieli: englanti
Lähde: NLM (National Library of Medicine)
Testosterone (UNII: 3XMK78S47O) (Testosterone - UNII:3XMK78S47O)
Dr. Reddy's Laboratories, Inc.
TRANSDERMAL
PRESCRIPTION DRUG
Testosterone gel 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: - Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. - Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations, but have gonadotropins in the normal or low range. Limitations of use: - Safety and efficacy of testosterone gel 1.62% in men with “age-related hypogonadism” (also referred to as “lat
Testosterone gel 1.62% is supplied in non-aerosol, metered-dose pumps that deliver 20.25 mg of testosterone per complete pump actuation. The pumps are composed of plastic and stainless steel and an LDPE/aluminum foil inner liner encased in rigid plastic with a polypropylene cap. Each 88 g metered-dose pump is capable of dispensing 75 g of gel or 60-metered pump actuations; each pump actuation dispenses 1.25 g of gel. Store at controlled room temperature 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Used testosterone gel 1.62% pumps should be discarded in household trash in a manner that prevents accidental application or ingestion by children or pets.
Abbreviated New Drug Application
TESTOSTERONE- TESTOSTERONE GEL, METERED DR. REDDY'S LABORATORIES, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE TESTOSTERONE GEL 1.62% SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR TESTOSTERONE GEL 1.62%. TESTOSTERONE GEL 1.62% FOR TOPICAL USE CIII INITIAL U.S. APPROVAL: 1953 WARNING: SECONDARY EXPOSURE TOTESTOSTERONE _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ VIRILIZATION HAS BEEN REPORTED IN CHILDREN WHO WERE SECONDARILY EXPOSED TO TESTOSTERONE GEL (5.2, 6.2). CHILDREN SHOULD AVOID CONTACT WITH UNWASHED OR UNCLOTHED APPLICATION SITES IN MEN USING TESTOSTERONE GEL (2.2, 5.2). HEALTHCARE PROVIDERS SHOULD ADVISE PATIENTS TO STRICTLY ADHERE TO RECOMMENDED INSTRUCTIONS FOR USE (2.2, 5.2, 17). INDICATIONS AND USAGE Testosterone gel 1.62% is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) (1) Hypogonadotropic hypogonadism (congenital or acquired) (1) Limitations of use: Safety and efficacy of testosterone gel 1.62% in men with “age-related hypogonadism” have not been established. (1) Safety and efficacy of testosterone gel 1.62% in males less than 18 years old have not been established. (1, 8.4) Topical testosterone products may have different doses, strengths, or application instructions that may result in different systemic exposure. (1, 12.3) DOSAGE AND ADMINISTRATION DOSAGE AND ADMINISTRATION FOR TESTOSTERONE GEL 1.62% DIFFERS FROM TESTOSTERONE GEL 1%. FOR DOSAGE AND ADMINISTRATION OF TESTOSTERONE GEL 1% REFER TO ITS FULL PRESCRIBING INFORMATION. (2) Prior to initiating testosterone gel 1.62%, confirm the diagnosis of hypogonadism by ensuring that serum testosterone has been measured in the morning on at least two separate days and that these concentrations are below the normal range (2). Starting dose of testosterone gel 1.62% is 40.5 mg of testosterone (2 pump actuations), applie Lue koko asiakirja